These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21951164)

  • 1. Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort.
    Smallwood A; Oulhaj A; Joachim C; Christie S; Sloan C; Smith AD; Esiri M
    Neuropathol Appl Neurobiol; 2012 Jun; 38(4):337-43. PubMed ID: 21951164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).
    Esiri MM; Joachim C; Sloan C; Christie S; Agacinski G; Bridges LR; Wilcock GK; Smith AD
    Alzheimer Dis Assoc Disord; 2014; 28(1):30-5. PubMed ID: 23842286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.
    Arvanitakis Z; Capuano AW; Leurgans SE; Bennett DA; Schneider JA
    Lancet Neurol; 2016 Aug; 15(9):934-943. PubMed ID: 27312738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.
    Banerjee G; Jang H; Kim HJ; Kim ST; Kim JS; Lee JH; Im K; Kwon H; Lee JM; Na DL; Seo SW; Werring DJ
    J Alzheimers Dis; 2018; 63(4):1485-1497. PubMed ID: 29843234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CAMCOG: a useful screening instrument for dementia in stroke patients.
    de Koning I; van Kooten F; Dippel DW; van Harskamp F; Grobbee DE; Kluft C; Koudstaal PJ
    Stroke; 1998 Oct; 29(10):2080-6. PubMed ID: 9756586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different cognitive profiles between mild cognitive impairment due to cerebral small vessel disease and mild cognitive impairment of Alzheimer's disease origin.
    Zhou A; Jia J
    J Int Neuropsychol Soc; 2009 Nov; 15(6):898-905. PubMed ID: 19891819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does EEG (visual and quantitative) reflect mental impairment in subcortical vascular dementia?
    Gawel M; Zalewska E; Szmidt-Sałkowska E; Kowalski J
    J Neurol Sci; 2007 Jun; 257(1-2):11-6. PubMed ID: 17337009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C as an index of cerebral small vessel disease: results of a cross-sectional study in community-based Japanese elderly.
    Wada M; Nagasawa H; Kawanami T; Kurita K; Daimon M; Kubota I; Kayama T; Kato T
    Eur J Neurol; 2010 Mar; 17(3):383-90. PubMed ID: 19832902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular pathologies and cognition in a population-based cohort of elderly people.
    Fernando MS; Ince PG;
    J Neurol Sci; 2004 Nov; 226(1-2):13-7. PubMed ID: 15537512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
    Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
    J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease.
    Schwartz RS; Halliday GM; Soh D; Cordato DJ; Kril JJ
    J Clin Neurosci; 2018 Dec; 58():70-74. PubMed ID: 30327218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cognitive impairment in small vessel disease: clinical and neuropsychological features of lacunar state and Binswanger's disease.
    Ramos-Estebanez C; Moral-Arce I; Gonzalez-Mandly A; Dhagubatti V; Gonzalez-Macias J; Munoz R; Hernadez-Hernandez JL
    Age Ageing; 2011 Mar; 40(2):175-80. PubMed ID: 21239411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
    Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol.
    van Norden AG; de Laat KF; Gons RA; van Uden IW; van Dijk EJ; van Oudheusden LJ; Esselink RA; Bloem BR; van Engelen BG; Zwarts MJ; Tendolkar I; Olde-Rikkert MG; van der Vlugt MJ; Zwiers MP; Norris DG; de Leeuw FE
    BMC Neurol; 2011 Feb; 11():29. PubMed ID: 21356112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease.
    Brookes RL; Hannesdottir K; Lawrence R; Morris RG; Markus HS
    Age Ageing; 2012 Mar; 41(2):212-8. PubMed ID: 22267862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impact of subcortical vascular and Alzheimer's disease pathology.
    Chui HC; Zarow C; Mack WJ; Ellis WG; Zheng L; Jagust WJ; Mungas D; Reed BR; Kramer JH; Decarli CC; Weiner MW; Vinters HV
    Ann Neurol; 2006 Dec; 60(6):677-87. PubMed ID: 17192928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
    Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ
    Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.